New cancer clinical trial: Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies
Published on: January 01, 2019
Condition: Cancer
Intervention: Drug: JTX-4014
Sponsor: Jounce Therapeutics, Inc.
Recruiting
http://bit.ly/2s2tQIG Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies
Condition: Cancer
Intervention: Drug: JTX-4014
Sponsor: Jounce Therapeutics, Inc.
Recruiting
http://bit.ly/2s2tQIG Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies
Comments
Post a Comment